1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase II Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Patients With mCRPCMetastatic Castration-resistant Prostate Cancer (mCRPC)RecruitingPhase 22025-08-27NCT06241846